FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 14

Author

Admin 422 posts 0 comments

Uncategorized

Balancing Control, Cost and Innovation: What’s at Stake When Systems Fall…

Admin Sep 25, 2025
Your roadmap to cost savings, innovation, and operational excellence. Engineering Document Management Systems…
Whitepaper

3 GenAI Use Cases That Immediately Benefit Finance Departments

Admin Sep 24, 2025
Explore how generative AI can transform finance operations. This guide outlines 3 high-impact use cases, including…
Uncategorized

India’s GST 2.0 Reform Sparks Surge in Consumer Spending & Auto Sector Demand

Admin Sep 23, 2025
India’s implementation of the upgraded Goods & Services Tax regime (GST 2.0) has had immediate and tangible…
Featured News

India Slashes GST Rates on Daily Food Items Under GST 2.0: What It Means for…

Admin Sep 22, 2025
India has embarked on one of its most sweeping reforms to the Goods and Services Tax (GST) system, officially…
Articles

Gambling Apps Banned Due to Financial Risks

Admin Sep 19, 2025
In recent years, the rapid growth of online gambling applications has raised significant concerns for…
Featured News

A Finance Leader’s Guide to AI-Readiness

Admin Sep 18, 2025
AI is transforming finance, but 80% of AI project time is wasted on data prep. This guide reveals the 3 pillars of…
Featured News

Finance Ministry Calls for Relief for Small Gold Loan Borrowers Under New RBI…

Admin Sep 17, 2025
The Finance Ministry of India has taken a key step to protect small borrowers by requesting the Reserve Bank of…
Featured News

Amazon’s Acquisition of Axio Enables Direct Lending Play in India

Admin Sep 12, 2025
In a strategic move, Amazon has finalized its acquisition of the fintech company Axio, which gives Amazon direct…
Featured News

Global Markets React to Rising Oil Prices as Inflation Concerns Resurface

Admin Sep 10, 2025
Global financial markets witnessed heightened volatility today as crude oil prices surged past $95 per barrel,…
Featured News

Credit Card and SIP Scams: Separating Fraud from Facts

Admin Sep 9, 2025
In recent weeks, the spotlight has fallen on the surge of credit card scams and misleading narratives around…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Everything You Should Know About Contactless Payments
    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future
    • 5 Approaches to Scaling Finance Accuracy with AI

    ARTICLE

    JellyTide Claims Evaluated: The Gelatin Trick Recipe + Baking Soda Shot with Lemon for Weight Loss Using Jelly Tide Gummies
    2026-05-14T00:21:29Z
    JellyTide Scam or Legit? BHB Salts, Apple Cider Vinegar Gummies, Side Effects, Dosage, and 60-Day Guarantee Explained


    Hard Chews Gummies Claims Evaluated: Investigating the Salt Tonic Trick Recipe for Men
    2026-05-13T22:20:56Z
    Hard Chews Gummies Ingredients, Male Performance Support, L-Arginine, Tongkat Ali, Maca Root, 180-Day Guarantee, Pricing, and Subscribe and Save Researched


    Venus Concept Announces Senior Management Changes
    2026-05-13T21:25:00Z
    TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced changes to its senior leadership team.


    Management team’s 2025 market-based Options have vested
    2026-05-13T21:00:00Z
    Share price increase from $6 to $30 triggers full vesting


    Aptose Reports First Quarter 2026 Results 
    2026-05-13T21:00:00Z
    SAN DIEGO and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib...


    ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-13T20:55:00Z
    LIGHTHOUSE POINT, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (OTCQB: ZVSA), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of inflammatory and renal diseases...


    Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights
    2026-05-13T20:35:00Z
    - Composition of matter provisional patent application filed for a new form of brilaroxazine designed to extend patent life and commercial exclusivity through 2046 - - FDA feedback on use...


    Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results
    2026-05-13T20:30:00Z
    Conference Call Scheduled for today, May 13, 2026, at 5:00pm ET


    Park Dental Partners Announces First Quarter 2026 Results
    2026-05-13T20:30:00Z
    MINNEAPOLIS, May 13, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its first-quarter...


    Combined General Meeting of June 3, 2026
    2026-05-13T20:30:00Z
    Châtillon, France, May 13, 2026


    EDAP | Focal One to Host Investor Day on June 1, 2026
    2026-05-13T20:30:00Z
    , May 13, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Host Investor Day on June 1, 2026


    Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
    2026-05-13T20:25:58Z
    LEXINGTON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the...


    Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
    2026-05-13T20:07:25Z
    First clinical data from PRMT5/RAS(ON) combination trial to be presented in 2026


    Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
    2026-05-13T20:05:00Z
    CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human...


    SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates
    2026-05-13T20:05:00Z
    Added 7 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue


    Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
    2026-05-13T20:05:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach...


    Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-13T20:05:00Z
    Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026


    Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress
    2026-05-13T20:05:00Z
    JUPITER, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered,...


    Bionano Reports First Quarter 2026 Results and Provides a Business Update
    2026-05-13T20:05:00Z
    Conference call today, May 13, 2026, at 4:30 PM ET


    LogicMark, Inc. Announces Strong First Quarter 2026 Results
    2026-05-13T20:05:00Z
    Revenue Up 24% as Gross Margin Expands to 69.6% and Operating Loss Narrows


    IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
    2026-05-13T20:05:00Z
    NASHVILLE, Tenn., May 13, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in conjunction with its first quarter results:


    Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
    2026-05-13T20:05:00Z
    100% insulin independence achieved in 10 patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led study


    Glass House Brands Reports First Quarter 2026 Financial Results
    2026-05-13T20:05:00Z
    LONG BEACH, Calif. and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF),...


    Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
    2026-05-13T20:05:00Z
    REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial...


    Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
    2026-05-13T20:05:00Z
    CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with...


    Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update
    2026-05-13T20:05:00Z
    MIAMI, May 13, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today reported financial...


    Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
    2026-05-13T20:03:27Z
    ORKA-001 EVERLAST-A 16-week data showed 63.5% PASI 100 rate and a favorable tolerability profile, with longer-term data expected in 2H 2026


    Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update
    2026-05-13T20:02:00Z
    SOUTH SAN FRANCISCO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for...


    vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
    2026-05-13T20:01:00Z
    Phase 3 CATT1 completion of enrollment on track for the third quarter of 2026


    Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights
    2026-05-13T20:01:00Z
    Phase 1 proof-of-mechanism study of EQ504 on track to initiate in mid-2026, with data expected approximately six months thereafter

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.